Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Covington
US Department of Justice
Julphar
Daiichi Sankyo
Dow
QuintilesIMS
Novartis
AstraZeneca
Fish and Richardson

Generated: October 19, 2017

DrugPatentWatch Database Preview

Drug Master Files for: rizatriptan

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
17633AII8/30/2004CIPLA LTDRIZATRIPTAN BENZOATE
18021AII1/26/2005CIPLA LTDRIZATRIPTAN BENZOATE USP
19098AII1/10/2006MYLAN LABORATORIES LTDRIZATRIPTAN BENZOATE USP
19179AII2/14/2006DR REDDYS LABORATORIES LTDRIZATRIPTAN BENZOATE USP
20781AII8/21/2007NATCO PHARMA LTDRIZATRIPTAN BENZOATE
22676AII3/31/2009GLENMARK PHARMACEUTICALS LTDRIZATRIPTAN BENZOATE USP
22763AII5/8/2009NATCO PHARMA LTDRIZATRIPTAN BENZOATE (ROUTE - 2; PRODUCT CODE: RTB)
23066AII8/26/2009SMS PHARMACEUTICALS LTDRIZATRIPTAN BENZOATE
23581AII5/28/2010SUN PHARMACEUTICAL INDUSTRIES LTDRIZATRIPTAN BENZOATE USP
23598AII2/23/2010ZHEJIANG SUPOR PHARMACEUTICALS CO LTDRIZATRIPTAN BENZOATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
McKinsey
Healthtrust
Fuji
McKesson
Merck
Mallinckrodt
Baxter
Queensland Health
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot